KRONOXCommodities

Kronox Lab Sciences Limited

Specialty Chemicals · ISIN INE0ATZ01017 · BSE 544187 · NSE BE · FV ₹10
Last price
₹197
-0.21%today
What this company does

Kronox Lab Sciences Limited operates in Specialty Chemicals, part of the Commodities sector. It booked ₹28 cr of revenue in its latest quarter (Q1 FY27) and kept 25.7% of sales as profit.

72out of 100
Equitytale Health Score
Solid

Healthier than 72% of companies in Commodities, on the 5 of 6 measures we could read for it. Each measure is ranked against the 42–176 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
51

At close. Not part of the score.

Profitability & returns89

How much profit it earns on the money it employs

Balance sheet91

How much it owes, and whether earnings cover the interest

Cash quality66

Whether reported profit actually arrives as cash

Valuation7

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Strengths
✓ Makes a profit
✓ Strong 26% net margin
✓ Sales up 17% vs last year
✓ Profit up 16% vs last year
✓ Promoters hold 64%
✓ No promoter shares pledged
✓ Strong 25% return on equity
✓ Virtually debt-free
✓ Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in KRONOX?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 15% a year, it would become
₹26.30 lakh

The slider starts at 15%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹197▼ -0.21%
latest close · 2026-11-04
52-wk low ₹14474 sessions so far52-wk high ₹228
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio24.7Average
LowAverageHigh
P/B ratio6.30High
Below bookModerateHigh
EV / EBITDA17.7High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity25.2%Strong
WeakFairStrong ▸15%
Return on capital33.6%Strong
WeakFairStrong
Net margin25.7%Strong
ThinDecentStrong
EBITDA margin36.3%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.01Comfortable
LowModerateHigh ▸1
Interest cover298.3×Strong
RiskyOkayStrong ▸5×
Current ratio7.60Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹732 cr
Book value
₹31
EPS
₹2.00
latest quarter
Net debt
₹-1 cr
more cash than debt
Enterprise value
₹731 cr
EBITDA
₹41 cr
annualised
EBIT
₹39 cr
annualised
Operating margin
34.7%
Return on assets
22.9%
Earnings yield
4.05%
P/S
6.45
Sales / share
₹30.6
Tax rate
25.6%
Face value
₹10
Shares
3.7 cr
Working capital
₹68 cr
Current assets
₹79 cr
Current liabilities
₹10 cr
Delivery %
40.9%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-04.

Worth vs price · from the exchange filings
not investment advice
Looks overpricedMedium confidence
Median of 2 models ₹89 vs market price ₹197 — price is 121% above it
Safety cushion-121.0%(target ≥ +20%)
Models span ₹75–₹103, midpoint ₹89
Model ₹89
Price ₹197
Cheap sideExpensive side

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹28 cr
Other Income₹1 cr
Total Income₹30 cr
Cost of Materials₹15 cr
Purchases of Stock-in-Trade₹0 cr
Inventory Change (±)₹-1 cr
Employee Benefit Expense₹2 cr
Finance Costs₹3.3 L
Depreciation & Amortisation₹45.2 L
Other Expenses₹3 cr
Total Expenses₹20 cr
Profit before Tax₹10 cr
Tax Expense₹3 cr
Net Profit₹7 cr
Net margin on total income24.6%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹14 cr47.1%
Employee benefit expense₹2 cr6.5%
Finance costs₹3.3 L0.1%
Depreciation & amortisation₹45.2 L1.5%
Other expenses₹3 cr11.7%
Tax expense₹3 cr8.4%
Profit for the period₹7 cr24.6%
Total income ₹30 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue25 cr26 cr28 cr
Total income26 cr28 cr30 cr
Expenses18 cr17 cr20 cr
Profit before tax9 cr11 cr10 cr
Tax2 cr3 cr3 cr
Net profit (owners' share)7 cr8 cr7 cr
Net margin (owners' share, on revenue)26.1%30.6%25.7%
EPS (₹)1.792.182.00
YoY (latest quarter): total income +18.0% · net profit +16.3%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹128 cr
Shareholder equity
₹116 cr
parent shareholders
Total debt
₹2 cr
Cash
₹3 cr
Cash flow · H1 FY26
Operating
₹10 cr
Investing
₹-12 cr
Financing
₹76.1 L
Peer comparison
Specialty Chemicals · by market value
CompanyPriceMarket capP/E
Pidilite Industries Limited₹1,511₹1.54 L cr62.5
Gujarat Fluorochemicals Limited₹4,464₹49,103 cr55.3
Navin Fluorine International Limited₹8,530₹43,759 cr40.6
Deepak Nitrite Limited₹1,521₹20,741 cr13.0
Aether Industries Limited₹1,501₹19,924 cr73.3
Aarti Industries Limited₹439₹15,930 cr23.6
Fine Organic Industries Limited₹5,089₹15,603 cr25.6
Atul Limited₹5,073₹14,935 cr24.0
BASF India Limited₹3,138₹13,584 cr9.8
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
0.25%
trailing 12 months
Dividend / share (TTM)
₹0.5
Last dividend
₹0.5
ex 9 Sep 2026
ActionDetailEx-date
Dividend₹0.5 / share9 Sep 2026
Dividend₹0.5 / share8 Aug 2025
Dividend₹0.5 / share23 Aug 2024
Who owns it · 2026-09-30
No pledge
Promoter
64.3%
FII / Foreign
0.1%
DII / Domestic
2.5%
Retail / others
33.1%
Promoter stake down 9.9% over the last 11 quarters.
Smart-money activity
Insider trades
SoldMr. Pritesh Ramani · Promoter67.11 L · ₹69.3 cr29 Sep 26
SoldMr. Ketan Ramani · Promoter85.66 L · ₹88.4 cr29 Sep 26
SoldMr. Jogindersingh Jaswal · Promoter85.66 L · ₹88.4 cr29 Sep 26
Bulk / block deals
SoldVINSUL MAKARDI LTD · NSE2.50 L @ ₹210.0321 Aug 26
BoughtVINSUL MAKARDI LTD · NSE2.50 L @ ₹210.0521 Aug 26
SoldSILVERLEAF CAPITAL SERVICES PRIVATE LIMITED · NSE2.29 L @ ₹205.6721 Aug 26
Stake changes
SoldPritesh Vinodchandra Ramani · promoter→ 3.32% · 67.11 L29 Sep 26
SoldIndo Borax & Chemicals Limited · promoter→ 3.32% · 85.66 L29 Sep 26
BoughtIndo Borax & Chemicals Limited · promoter→ 64.26% · 2.38 cr29 Sep 26
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 16 Sep 2026
See the official result
1
To receive, consider and adopt the Audited Standalone Financial Statement of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors thereon.
Backed by 75% of shareholders other than promotersneeded 50%
15,410 votes for, 5,001 against · 0% of mutual funds and other big investors said no
2
To declare a final dividend of Rs. 0.50/- per equity share for the financial year 2025-26.
Backed by 75% of shareholders other than promotersneeded 50%
15,410 votes for, 5,001 against · 0% of mutual funds and other big investors said no
3
To appoint a Director in place of Mr. Jogindersingh Jaswal (DIN: 02385809), who retires by rotation, and being eligible, offers himself for re-appointment.
Promoters had a personal stake in this
Backed by 75% of shareholders other than promotersneeded 50%
15,410 votes for, 5,001 against · 0% of mutual funds and other big investors said no
4
To ratify the remuneration payable to the Cost Auditors for the financial year 2026-27.
Backed by 75% of shareholders other than promotersneeded 50%
15,410 votes for, 5,001 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 2 named members
owning 64.3% between them · as of 2026-09-30
INDO BORAX & CHEMICALS LIMITED64.26%
ZENROCK CHEMICALS PRIVATE LIMITEDno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.